Additionally, the novel albumin-bilirubin grade (ALBI) score has recently been used to assess the prognosis of all types and stages of CLD, not just hepatocellular carcinoma (Toyoda & Johnson, 2022; Demirtas et al., 2021). The gene discussed is ALB; the disease is congenital secretory chloride diarrhea 1.